Addyi Tablet, Film Coated
Product Images NDC 58604-214

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Addyi (NDC 58604-214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sprout Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Addycarton New

Addycarton New
This appears to be a label or packaging information for a medication called "flibanserin" tablets in 100mg dosage. It instructs to avoid coating a certain area on the tablets and to store them at a temperature of 25°C. The label also includes the medication code and quantity of 30 tablets.*
FDA Label Image

Addyibottle New

Addyibottle New
This is a medication called EleeV (fibanserin) that comes in 30 tablets of 100mg each. The recommended dosage is to take one tablet daily at bedtime. The medication should be stored at 25°C (77°F) and the accompanying medication guide should be dispensed to each patient. Additionally, it is important to keep the medication out of reach of children.*
FDA Label Image

Addyibottle

Addyibottle
This is a medication guide for Flibanserin tablets, manufactured by Sprout Pharmaceuticals. The tablets contain 100mg of Flibanserin and the recommended dosage is once a day at bedtime. The medication guide should be provided to each patient by the pharmacist. The tablets come in 30-tablet packaging and should be stored at 25°C. Expiry and lot numbers are not available.*
FDA Label Image

Addyicarton.jpg (Addyicarton)

Addyicarton.jpg (Addyicarton)
This is a medication packaging for Addyi (flibanserin) tablets. It contains 100mg tablets and must be taken once daily at bedtime. The tablets should be stored at 25°C (17°F). The packaging includes a medication guide for each patient. There is a "NO COATING AREA" indicated on the packaging.*
FDA Label Image
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
The text describes a graph showing the plasma concentration-time profile for Flibanserin in healthy female subjects after a single oral dose of 100 mg. The graph shows mean and standard deviation values on a linear scale for plasma Flibanserin concentration at different time points.*
FDA Label Image

Structural Formula (Structuralformula)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.